Viewing nowCombinationRosaplus-EF Tablet
Losartan Potassium 100mg · Hydrochlorothiazide 25mg
Tablet · Prescription medication · Combination
Korea Pavis Pharmaceutical Co., Ltd.

MFDS item code 200607942 · Notified 2006.07.27 · Insurance code 621802090
Treatment of hypertension not controlled with monotherapy
This medication is used for patients with hypertension that is not adequately controlled with monotherapy.
○ Adults The usual dose of this medicine is one tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily. Doses exceeding losartan potassium 100 mg/hydrochlorothiazide 25 mg per day are not recommended. The maximum blood pressure-lowering effect generally occurs approximately 3 weeks after starting treatment. This medicine may be administered with other antihypertensive agents and may be taken with or without food. To minimize adverse reactions, start this medicine when the desired effect is not achieved with monotherapy. 1. Replacement therapy: A combination regimen of individually dose-adjusted losartan potassium and hydrochlorothiazide may be replaced with this medicine. 2. Patients whose blood pressure is not controlled with losartan or hydrochlorothiazide monotherapy: Start with one tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of one tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. 3. Patients whose blood pressure is not controlled with losartan potassium 100 mg monotherapy: Start with losartan potassium 100 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of one tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. 4. Patients whose blood pressure is not controlled with hydrochlorothiazide 25 mg once daily, or who develop hypokalemia even when their blood pressure is controlled at this dose: Treatment may be started with one tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily, which allows the hydrochlorothiazide dose to be reduced without reducing the overall blood pressure-lowering effect. Thereafter, monitor the clinical response to losartan potassium 50 mg/hydrochlorothiazide 12.5 mg continuously. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of one tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. ○ Patients with renal impairment Use the usual dose in patients with a creatinine clearance of 30 mL/min or more. Administration to these patients is not recommended, as loop diuretics are preferable to thiazide drugs in patients with more severe renal impairment. ○ Patients with hepatic impairment Administration to these patients is not recommended because this medicine cannot provide the initial dose of losartan potassium, 25 mg, required for patients with hepatic impairment who need dose adjustment.
○ Pediatric patients (under 18 years) Because there is no experience with use in children and adolescents, the losartan-hydrochlorothiazide combination should not be administered to children or adolescents.
This medication can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. Patients with allergies to this drug or its components, certain kidney diseases, liver diseases, or electrolyte imbalances should not take this medication. Patients with specific diseases or conditions such as hypotension, kidney impairment, liver impairment, hyperuricemia, diabetes, or the elderly should exercise special caution when taking this medication. During treatment, blood pressure, kidney function, and electrolyte levels should be monitored regularly to check for abnormal signs, with particular attention to hypokalemia or hyperkalemia. This drug has a blood pressure-lowering effect, so dizziness or drowsiness may occur when starting or adjusting the dose, which requires caution when driving or operating machinery. There may be interactions with other drugs, so it is essential to consult a doctor or pharmacist, especially if taking potassium supplements, diuretics, antihypertensives, non-steroidal anti-inflammatory drugs (NSAIDs), or lithium. The hydrochlorothiazide component can react sensitively to sunlight, so prolonged exposure to sunlight should be avoided; if there are skin reactions, notify a doctor immediately. Pregnant women or women who may become pregnant should not take this medication, and breastfeeding women should either discontinue breastfeeding or consult a doctor before taking it. Safety for children and adolescents has not been established, so this medication should not be administered to minors. Overdose may result in symptoms such as hypotension, changes in heart rate, and electrolyte imbalances, so if abnormal symptoms occur, medical attention should be sought immediately. This medication should be stored in its original container, kept out of the reach of children, and not shared or transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This drug is sensitive to light and should be stored in a container that blocks light. It is also recommended to store the medication at room temperature, between 1 and 30 degrees Celsius.
Pale yellow oval film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationLosartan Potassium 100mg · Hydrochlorothiazide 25mg
Tablet · Prescription medication · Combination
Korea Pavis Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Yuhan
CombinationLosartan Potassium 100mg · Hydrochlorothiazide 25mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
(Co., Ltd. ) Yuyoung Pharmaceutical
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Youngpoong Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Kolon Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 100mg · Hydrochlorothiazide 25mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Dongkwang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.